2 results
Approved WMOCompleted
The primary objective is to assess whether a 10-14 day Merocel with TC packing of the sinus is better than a one day Merocel with TC packing in the improvement of clinical and sinus parameters in patients with symmetrical CRSwNP following FESS. The…
Approved WMOCompleted
Therapy:The investigational product, ACP-196, will be supplied as hardgelatin capsules for oral administration.Commercially available ibrutinib (IMBRUVICA®) will be used asthe reference therapy.Objectives: Primary Objective:To assess whether ACP-196…